FTO and ovarian carcinoma: Similar to the findings of this study, another study confirmed that low FTO expression was associated with higher FIGO staging in ovarian cancer patients and that FTO decreased the m6A level and stability of SNAI1 mRNA, leading to downregulation of SNAI1 expression and inhibition of the epithelial-mesenchymal transition [135].